Fercy Warning Letter Confirms OTC Monograph Fears
This article was originally published in The Gold Sheet
Executive Summary
Drug maker in China found to exploit gap in U.S. regulatory system, exporting OTC monograph drugs without key quality controls or registration until FDA inspection led to import suspension.